TransMedics: 2027 Setting Up To Be A Pivotal Year
TransMedics Group, Inc. 2026 Q3 - Results - Earnings Call Presentation
TransMedics (TMDX) Just Reclaimed the 200-Day Moving Average
TransMedics: Growth Is Accelerating Again And 2027 Looks Promising
TransMedics: 3 Key Takeaways for Long-Term Investors
UBS Maintains Neutral on TransMedics Group, Raises Price Target to $88
TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average
TransMedics Group Q3 Earnings Call Highlights
Needham Maintains Buy on TransMedics Group, Raises Price Target to $110
TransMedics Stock Gains Attention After Revenue Guidance Raise
Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $120
TransMedics Group, Inc. Q3 2026 Earnings Call Summary
TransMedics Group Inc (TMDX) (Q3 2026) Earnings Call Highlights: Record $203 Million Revenue ...
TransMedics (TMDX) Q3 2026 Earnings Call Transcript
TransMedics (TMDX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
TransMedics Group Inc (NASDAQ:TMDX) Q3 Beat and Raised Outlook Spark After-Hours Rally
TransMedics Group, Inc. (TMDX) Q3 2026 Earnings Call Transcript
TransMedics: Q3 Earnings Snapshot
TransMedics Reports Third Quarter 2026 Financial Results
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.